Swedish Orphan Biovitrum AB (publ)
SWB:B6E
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Swedish Orphan Biovitrum AB (publ)
SWB:B6E
|
SE |
|
Endava PLC
NYSE:DAVA
|
UK |
|
Panorama Sentrawisata Tbk PT
IDX:PANR
|
ID |
|
A
|
Amkor Technology Inc
F:AMK
|
US |
|
SRT Marine Systems PLC
LSE:SRT
|
UK |
|
M
|
Mayora Indah Tbk PT
XMUN:D7V
|
ID |
|
Amala Foods PLC
F:7QQ
|
JE |
|
I
|
IPH Ltd
OTC:IPHLF
|
AU |
|
U
|
Upwork Inc
F:UP2
|
US |
|
E
|
EnerSys
DUS:FDN
|
US |
|
Burford Capital Ltd
F:9BFA
|
GG |
|
Askoll Eva SpA
F:736
|
IT |
|
J
|
Johnson & Johnson
F:JNJ
|
US |
|
Eurofins Scientific SE
PAR:ERF
|
LU |
|
Semiconductor Manufacturing International Corp
SSE:688981
|
CN |
|
T
|
Tate & Lyle PLC
OTC:TATYY
|
UK |
|
T
|
Takeda Pharmaceutical Co Ltd
XBER:TKD
|
JP |
|
O
|
OHB SE
SWB:OHB
|
DE |
|
S
|
Sixt SE
SWB:SIX2
|
DE |
|
P
|
Preferred Apartment Communities Inc
F:P2A
|
US |
|
Sezzle Inc
F:0SE0
|
US |
|
S
|
Sixt SE
F:SIX2
|
DE |
|
Hexagon Purus ASA
F:0QJ
|
NO |
|
O
|
Organon & Co
XMUN:7XP
|
US |
Wall St Price Targets
B6E Price Targets Summary
Swedish Orphan Biovitrum AB (publ)
According to Wall Street analysts, the average 1-year price target for B6E is 42.29 EUR with a low forecast of 28.2 EUR and a high forecast of 50.46 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is B6E's stock price target?
Price Target
42.29
EUR
According to Wall Street analysts, the average 1-year price target for B6E is 42.29 EUR with a low forecast of 28.2 EUR and a high forecast of 50.46 EUR.
What is the Revenue forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 23%. The projected CAGR for the next 8 years is 9%.
What is the Operating Income forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
9%
The compound annual growth rate for Operating Income over the next 8 years is 9%.
What is the Net Income forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
50%
The compound annual growth rate for Net Income over the next 8 years is 50%.
